In a report released today, Benjamin Theurer from Barclays maintained a Hold rating on Corteva (CTVA – Research Report), with a price target of $58.00. The company’s shares closed yesterday at $53.91.
Theurer covers the Consumer Defensive sector, focusing on stocks such as Coca Cola Femsa SAB De CV, Pilgrim’s Pride, and Ingredion. According to TipRanks, Theurer has an average return of 5.9% and a 55.83% success rate on recommended stocks.
Corteva has an analyst consensus of Moderate Buy, with a price target consensus of $62.57.
Based on Corteva’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $6.05 billion and a net profit of $714 million. In comparison, last year the company earned a revenue of $6.25 billion and had a net profit of $965 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Corteva (CTVA) Company Description:
Corteva, Inc. is an agricultural chemical and seed company. It develops and supplies advanced germplasm and traits that helps in maximizing yield for farms. It also supplies products that enhances enhance crop health and protectagainst weeds, insects and other pests, and diseases.
Read More on CTVA:
